These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15528268

  • 1. Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.
    Jorgensen R, Martini L, Schwartz TW, Elling CE.
    Mol Endocrinol; 2005 Mar; 19(3):812-23. PubMed ID: 15528268
    [Abstract] [Full Text] [Related]

  • 2. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL, Koehler JA, Yusta B, Drucker DJ.
    J Biol Chem; 2005 Jun 10; 280(23):22124-34. PubMed ID: 15817468
    [Abstract] [Full Text] [Related]

  • 3. Arrestin specificity for G protein-coupled receptors in human airway smooth muscle.
    Penn RB, Pascual RM, Kim YM, Mundell SJ, Krymskaya VP, Panettieri RA, Benovic JL.
    J Biol Chem; 2001 Aug 31; 276(35):32648-56. PubMed ID: 11418617
    [Abstract] [Full Text] [Related]

  • 4. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.
    Bisello A, Manen D, Pierroz DD, Usdin TB, Rizzoli R, Ferrari SL.
    Mol Endocrinol; 2004 Jun 31; 18(6):1486-98. PubMed ID: 14988434
    [Abstract] [Full Text] [Related]

  • 5. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
    Vilardaga JP, Frank M, Krasel C, Dees C, Nissenson RA, Lohse MJ.
    J Biol Chem; 2001 Sep 07; 276(36):33435-43. PubMed ID: 11387315
    [Abstract] [Full Text] [Related]

  • 6. Development of a BRET2 screening assay using beta-arrestin 2 mutants.
    Vrecl M, Jorgensen R, Pogacnik A, Heding A.
    J Biomol Screen; 2004 Jun 07; 9(4):322-33. PubMed ID: 15191649
    [Abstract] [Full Text] [Related]

  • 7. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
    Huet E, Boulay F, Barral S, Rabiet MJ.
    Cell Signal; 2007 Sep 07; 19(9):1939-48. PubMed ID: 17594911
    [Abstract] [Full Text] [Related]

  • 8. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
    Ouedraogo M, Lecat S, Rochdi MD, Hachet-Haas M, Matthes H, Gicquiaux H, Verrier S, Gaire M, Glasser N, Mély Y, Takeda K, Bouvier M, Galzi JL, Bucher B.
    Traffic; 2008 Mar 07; 9(3):305-24. PubMed ID: 18088318
    [Abstract] [Full Text] [Related]

  • 9. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
    Shenoy SK, Lefkowitz RJ.
    J Biol Chem; 2003 Apr 18; 278(16):14498-506. PubMed ID: 12574160
    [Abstract] [Full Text] [Related]

  • 10. Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s).
    Jorgensen R, Kubale V, Vrecl M, Schwartz TW, Elling CE.
    J Pharmacol Exp Ther; 2007 Jul 18; 322(1):148-54. PubMed ID: 17395766
    [Abstract] [Full Text] [Related]

  • 11. NK1 receptor fused to beta-arrestin displays a single-component, high-affinity molecular phenotype.
    Martini L, Hastrup H, Holst B, Fraile-Ramos A, Marsh M, Schwartz TW.
    Mol Pharmacol; 2002 Jul 18; 62(1):30-7. PubMed ID: 12065752
    [Abstract] [Full Text] [Related]

  • 12. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, Crivici A.
    Proc Natl Acad Sci U S A; 1999 Feb 16; 96(4):1569-73. PubMed ID: 9990065
    [Abstract] [Full Text] [Related]

  • 13. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3',5'-monophosphate signaling by beta-arrestin2.
    Ferrari SL, Bisello A.
    Mol Endocrinol; 2001 Jan 16; 15(1):149-63. PubMed ID: 11145746
    [Abstract] [Full Text] [Related]

  • 14. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
    Bonde MM, Hansen JT, Sanni SJ, Haunsø S, Gammeltoft S, Lyngsø C, Hansen JL.
    PLoS One; 2010 Nov 30; 5(11):e14135. PubMed ID: 21152433
    [Abstract] [Full Text] [Related]

  • 15. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
    Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Piñeyro G.
    Proc Natl Acad Sci U S A; 2003 Sep 30; 100(20):11406-11. PubMed ID: 13679574
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins.
    Key TA, Vines CM, Wagener BM, Gurevich VV, Sklar LA, Prossnitz ER.
    Traffic; 2005 Feb 30; 6(2):87-99. PubMed ID: 15634210
    [Abstract] [Full Text] [Related]

  • 17. A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.
    Lan H, Liu Y, Bell MI, Gurevich VV, Neve KA.
    Mol Pharmacol; 2009 Jan 30; 75(1):113-23. PubMed ID: 18809670
    [Abstract] [Full Text] [Related]

  • 18. Beta-arrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor upon receptor activation.
    Jorgensen R, Norklit Roed S, Heding A, Elling CE.
    Pharmacology; 2011 Jan 30; 88(3-4):174-81. PubMed ID: 21952200
    [Abstract] [Full Text] [Related]

  • 19. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization.
    Gray JA, Bhatnagar A, Gurevich VV, Roth BL.
    Mol Pharmacol; 2003 May 30; 63(5):961-72. PubMed ID: 12695524
    [Abstract] [Full Text] [Related]

  • 20. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling.
    Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC.
    Science; 2003 Sep 05; 301(5638):1394-7. PubMed ID: 12958365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.